Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 283 for Lung cancer

Edit search filters
  1. Evaluating The Addition Of The Immunotherapy Drug Atezolizumab To Standard Chemotherapy Treatment For Advanced Or Metastatic Neuroendocrine Carcinomas That Originate Outside The Lung

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A*02 Expression

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Phase 2 Trial Of Adagrasib Monotherapy And In Combination With Pembrolizumab And A Phase 3 Trial Of Adagrasib In Combination In Patients With A KRAS G12C Mutation KRYSTAL-7

    Jacksonville, FL, Rochester, MN

  4. Study Of TJ011133 In Participants With Relapsed/ Refractory Advanced Solid Tumors And Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of HFB200301 In Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of AL101 In Patients With Adenoid Cystic Carcinoma Bearing Activating Notch Mutations

    Rochester, MN

  7. A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, Following Complete Tumour Resection, In Participants With Stage I Adenocarcinoma NSCLC Who Are CtDNA-positive Or Have High-risk Pathological Features

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Understanding The Challenges, Behavioral Patterns, And Preferences Towards Participation In Clinical Trials In Minority Patient Populations

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Safety Study of Inhaled Saline in Acute Lung Injury

    Rochester, MN

  10. Lung-MAP: A Master Screening Protocol For Previously-Treated Non-Small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer